Abstract

BackgroundDecreased lung function is associated with non-alcoholic fatty liver disease (NAFLD), based on linking mechanisms such as insulin resistance and systemic inflammation However, its association with the risk of developing NAFLD is unclear. Our aim was to investigate whether baseline lung function is associated with incident NAFLD in middle-aged healthy Koreans.MethodsA cohort study of 96,104 subjects (mean age: 35.7 years) without NAFLD were followed up from 2002 to 2015. NAFLD was diagnosed by ultrasound after the exclusion of other possible causes of liver diseases. Baseline percent predicted forced expiratory volume in one second (FEV1%) and forced vital capacity (FVC%) were categorized in quartiles. Adjusted hazard ratios (aHR) and 95% confidence intervals (CIs) (using the highest quartile as reference) were calculated for incident NAFLD at follow-up, controlling for covariates and potential confounders.ResultsDuring 579,714.5 person-years of follow-up, 24,450 participants developed NAFLD (incidence rate, 42.2 per 1,000 person-years). The mean follow-up period was 5.9±3.4 years. Regardless of smoking history, the risk for incident NAFLD increased with decreasing quartiles of FEV1 (%) and FVC (%) in a dose-response manner (p for trend<0.001). In never smokers, the aHRs (95% CIs) for incident NAFLD were 1.15 (1.08–1.21), 1.11 (1.05–1.18), and 1.08 (1.02–1.14) in quartiles 1–3 for FEV1 (%) and 1.12 (1.06–1.18), 1.11 (1.05–1.18), and 1.09 (1.03–1.15) in quartiles 1–3 for FVC (%), compared with the highest quartile reference. Similar inverse association was present in smoke-exposed subjects (aHR for incident NAFLD were 1.14, 1.21, 1.13 and 1.17, 1.11, 1.09 across FEV1(%) and FVC(%) quartile in increasing order, respectively).ConclusionsReduced lung function was a risk factor for incident NAFLD in a large middle-aged Korean cohort with over half a million person-years of follow-up.

Highlights

  • Non-alcoholic fatty liver disease (NAFLD) is characterized by the presence of hepatic steatosis [1] and may progress over time to cirrhosis and hepatic failure [2]

  • non-alcoholic fatty liver disease (NAFLD) is associated with various extrahepatic complications such as cardio-metabolic diseases, chronic kidney disease, and sarcopenia [3,4,5,6,7], mediating increased low-grade systemic inflammation [8,9] which play a causal role in the development of NAFLD [8]

  • Previous studies have demonstrated that decreased lung function is associated with an increase in low-grade inflammation [10] and increased risk of diabetes, cardiovascular disease, and metabolic syndrome [11,12]

Read more

Summary

Introduction

Non-alcoholic fatty liver disease (NAFLD) is characterized by the presence of hepatic steatosis [1] and may progress over time to cirrhosis and hepatic failure [2]. NAFLD is associated with various extrahepatic complications such as cardio-metabolic diseases, chronic kidney disease, and sarcopenia [3,4,5,6,7], mediating increased low-grade systemic inflammation [8,9] which play a causal role in the development of NAFLD [8]. Previous studies have demonstrated that decreased lung function is associated with an increase in low-grade inflammation [10] and increased risk of diabetes, cardiovascular disease, and metabolic syndrome [11,12]. Decreased lung function is associated with non-alcoholic fatty liver disease (NAFLD), based on linking mechanisms such as insulin resistance and systemic inflammation its association with the risk of developing NAFLD is unclear.

Objectives
Methods
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call